KNW Valuation
Is A105330 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of A105330 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate A105330's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate A105330's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for A105330?
Other financial metrics that can be useful for relative valuation.
What is A105330's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ₩75.94b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.6x |
Enterprise Value/EBITDA | 8.1x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does A105330's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 0.7x | ||
A170920 LTCLtd | 0.6x | n/a | ₩92.7b |
A318410 BBC | 0.8x | n/a | ₩50.6b |
A010640 Chinyang Poly UrethaneLtd | 1.2x | n/a | ₩69.5b |
A004910 Chokwang Paint | 0.3x | n/a | ₩68.5b |
A105330 KNW | 0.9x | n/a | ₩75.9b |
Price-To-Sales vs Peers: A105330 is expensive based on its Price-To-Sales Ratio (0.9x) compared to the peer average (0.7x).
Price to Earnings Ratio vs Industry
How does A105330's PE Ratio compare vs other companies in the KR Chemicals Industry?
Price-To-Sales vs Industry: A105330 is expensive based on its Price-To-Sales Ratio (0.9x) compared to the KR Chemicals industry average (0.7x).
Price to Sales Ratio vs Fair Ratio
What is A105330's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 0.9x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate A105330's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.